Research on vitamin D metabolic regulation in the pathogenesis of related diseases
Objective:
To review the metabolic processes and regulatory mechanisms of vitamin D and their associations with disease pathogenesis, emphasizing the importance of vitamin D in disease prevention and providing a theoretical foundation for personalized clinical diagnosis and precision therapy.
Key Findings:
- 25(OH)D is the gold standard biomarker for assessing vitamin D status, crucial for monitoring health.
- CYP27B1 is expressed in extrarenal tissues, indicating local regulatory roles for vitamin D, which may influence treatment strategies.
- Dysregulation of vitamin D metabolism is linked to several diseases, underscoring the need for targeted interventions.
- 24,25(OH)2D may have independent biological functions and could serve as a novel biomarker, warranting further investigation.
Interpretation:
The findings underscore the importance of vitamin D metabolism in health and disease, suggesting that personalized approaches to vitamin D assessment and therapy could improve clinical outcomes, particularly in at-risk populations.
Limitations:
- The review may not cover all recent studies or emerging evidence in vitamin D research, particularly those published in the last year.
- Standardized protocols for vitamin D metabolomics are still in development, which may limit clinical application.
Conclusion:
Understanding vitamin D metabolism is crucial for developing targeted interventions in various diseases, highlighting the need for further research in specific areas such as vitamin D deficiency and its broader health implications.
